Immutep Ltd - Asset Resilience Ratio

Latest as of June 2025: 50.67%

Immutep Ltd (IMM) has an Asset Resilience Ratio of 50.67% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$79.54 Million

≈ $56.28 Million USD Cash + Short-term Investments

Total Assets

AU$156.98 Million

≈ $111.08 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Immutep Ltd's Asset Resilience Ratio has changed over time. Check Immutep Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Immutep Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Immutep Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$17.26 Million	10.99%
Short-term Investments	AU$62.28 Million	39.68%
Total Liquid Assets	AU$79.54 Million	50.67%

Asset Resilience Insights

Very High Liquidity: Immutep Ltd maintains exceptional liquid asset reserves at 50.67% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Immutep Ltd Industry Peers by Asset Resilience Ratio

Compare Immutep Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%

Annual Asset Resilience Ratio for Immutep Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Immutep Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	50.67%	AU$79.54 Million ≈ $56.28 Million	AU$156.98 Million ≈ $111.08 Million	+7.54pp
2024-06-30	43.13%	AU$86.94 Million ≈ $61.52 Million	AU$201.58 Million ≈ $142.63 Million	+40.70pp
2023-06-30	2.43%	AU$3.59 Million ≈ $2.54 Million	AU$147.45 Million ≈ $104.33 Million	+2.14pp
2022-06-30	0.30%	AU$302.00K ≈ $213.68K	AU$102.17 Million ≈ $72.29 Million	-9.80pp
2021-06-30	10.10%	AU$8.28 Million ≈ $5.86 Million	AU$82.03 Million ≈ $58.04 Million	-18.94pp
2020-06-30	29.03%	AU$13.53 Million ≈ $9.57 Million	AU$46.60 Million ≈ $32.97 Million	-6.43pp
2014-06-30	35.46%	AU$9.00 Million ≈ $6.37 Million	AU$25.38 Million ≈ $17.96 Million	+11.08pp
2013-06-30	24.38%	AU$8.00 Million ≈ $5.66 Million	AU$32.81 Million ≈ $23.22 Million	-26.19pp
2012-06-30	50.57%	AU$21.05 Million ≈ $14.89 Million	AU$41.61 Million ≈ $29.44 Million	+33.23pp
2011-06-30	17.35%	AU$10.00 Million ≈ $7.08 Million	AU$57.64 Million ≈ $40.78 Million	-35.25pp
2010-06-30	52.60%	AU$10.00 Million ≈ $7.08 Million	AU$19.01 Million ≈ $13.45 Million	+40.53pp
2007-06-30	12.07%	AU$526.17K ≈ $372.30K	AU$4.36 Million ≈ $3.08 Million	-28.43pp
2006-06-30	40.50%	AU$2.98 Million ≈ $2.11 Million	AU$7.36 Million ≈ $5.21 Million	-39.77pp
2005-06-30	80.28%	AU$7.33 Million ≈ $5.19 Million	AU$9.13 Million ≈ $6.46 Million	+79.93pp
2004-06-30	0.35%	AU$20.00K ≈ $14.15K	AU$5.77 Million ≈ $4.08 Million	-0.83pp
2001-06-30	1.18%	AU$50.00K ≈ $35.38K	AU$4.24 Million ≈ $3.00 Million	--

pp = percentage points

About Immutep Ltd

AU:IMM Australia Biotechnology

Market Cap

$48.95 Million

AU$69.18 Million AUD

Market Cap Rank

#21958 Global

#775 in Australia

Share Price

AU$0.05

Change (1 day)

+2.17%

52-Week Range

AU$0.04 - AU$0.46

All Time High

AU$0.68